[HTML][HTML] Treatment of liver fibrosis: Past, current, and future
Liver fibrosis accompanies the progression of chronic liver diseases independent of
etiologies, such as hepatitis viral infection, alcohol consumption, and metabolic-associated …
etiologies, such as hepatitis viral infection, alcohol consumption, and metabolic-associated …
Flavonoids from Whole-Grain Oat Alleviated High-Fat Diet-Induced Hyperlipidemia via Regulating Bile Acid Metabolism and Gut Microbiota in Mice
R Duan, X Guan, K Huang, Y Zhang, S Li… - Journal of Agricultural …, 2021 - ACS Publications
A high-fat diet (HFD) causes hyperlipidemia, which worsens disturbances in bile acid (BA)
metabolism and gut microbiota. This study aimed to investigate the regulation of flavonoids …
metabolism and gut microbiota. This study aimed to investigate the regulation of flavonoids …
Bile acid sequestrants for hypercholesterolemia treatment using sustainable biopolymers: Recent advances and future perspectives
Bile acids, the endogenous steroid nucleus containing signaling molecules, are responsible
for the regulation of multiple metabolic processes, including lipoprotein and glucose …
for the regulation of multiple metabolic processes, including lipoprotein and glucose …
Bile acids as metabolic regulators: an update
T Li, JYL Chiang - Current Opinion in Gastroenterology, 2023 - journals.lww.com
Basic and clinical studies have continued to discover novel roles of the enterohepatic bile
acid signaling in regulation of key metabolic pathways. Such knowledge forms the molecular …
acid signaling in regulation of key metabolic pathways. Such knowledge forms the molecular …
New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease
Y Liu, T Liu, X Zhao, Y Gao - Cellular and Molecular Life Sciences, 2022 - Springer
Cholestasis is a key causative factor in alcohol-related liver disease (ALD) and variable
degrees of cholestasis occur in all stages of ALD. However, the pathogenetic mechanisms …
degrees of cholestasis occur in all stages of ALD. However, the pathogenetic mechanisms …
[HTML][HTML] Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice
RF Kunst, I Bolt, RDJ van Dasselaar, BA Nijmeijer… - JHEP Reports, 2024 - Elsevier
Background & Aims Intestine-restricted inhibitors of the apical sodium-dependent bile acid
transporter (ASBT, or ileal bile acid transporter) are approved as treatment for several …
transporter (ASBT, or ileal bile acid transporter) are approved as treatment for several …
[HTML][HTML] Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
SG Rodrigues, S van der Merwe, A Krag… - Seminars in immunology, 2024 - Elsevier
“A healthy liver stands on a healthy gut” with the gut and its barriers representing the roots
that fuel the liver and expose it to an amazing diverse mixture of gut-derived material/agents …
that fuel the liver and expose it to an amazing diverse mixture of gut-derived material/agents …
Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice
W Zhao, M Xiao, X Wu, X Li, X Li, T Zhao… - Frontiers in …, 2021 - frontiersin.org
Bile acid (BA) metabolism is an attractive therapeutic target in nonalcoholic fatty liver
disease (NAFLD). We aimed to investigate the effect of ilexsaponin A1 (IsA), a major …
disease (NAFLD). We aimed to investigate the effect of ilexsaponin A1 (IsA), a major …
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice
Therapeutic reduction of hydrophobic bile acids exposure is considered beneficial in
cholestasis. The Cyp2c70 KO mice lack hydrophilic muricholic acids and have a human-like …
cholestasis. The Cyp2c70 KO mice lack hydrophilic muricholic acids and have a human-like …
Bile acid signaling in metabolic and inflammatory diseases and drug development
T Li, JYL Chiang - Pharmacological Reviews, 2024 - pharmrev.aspetjournals.org
Bile acids are the end products of cholesterol catabolism. Hepatic bile acid synthesis
accounts for a major fraction of daily cholesterol turnover in humans. Biliary secretion of bile …
accounts for a major fraction of daily cholesterol turnover in humans. Biliary secretion of bile …